IN2013MU01226A - - Google Patents
Info
- Publication number
- IN2013MU01226A IN2013MU01226A IN1226MU2013A IN2013MU01226A IN 2013MU01226 A IN2013MU01226 A IN 2013MU01226A IN 1226MU2013 A IN1226MU2013 A IN 1226MU2013A IN 2013MU01226 A IN2013MU01226 A IN 2013MU01226A
- Authority
- IN
- India
- Prior art keywords
- regadenoson
- amorphous
- provides
- stable
- preparation
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
The present invention provides a stable amorphous Regadenoson and process for preparation. Further, it provides stable pharmaceutical compositions of amorphous Regadenoson along with other pharmaceutically acceptable excipient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1226MU2013 IN2013MU01226A (en) | 2013-03-28 | 2013-03-28 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1226MU2013 IN2013MU01226A (en) | 2013-03-28 | 2013-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU01226A true IN2013MU01226A (en) | 2015-04-17 |
Family
ID=54395600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1226MU2013 IN2013MU01226A (en) | 2013-03-28 | 2013-03-28 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU01226A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10442832B2 (en) | 2015-02-06 | 2019-10-15 | Apicore Us Llc | Process of making regadenoson and novel polymorph thereof |
-
2013
- 2013-03-28 IN IN1226MU2013 patent/IN2013MU01226A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10442832B2 (en) | 2015-02-06 | 2019-10-15 | Apicore Us Llc | Process of making regadenoson and novel polymorph thereof |
US11034714B2 (en) | 2015-02-06 | 2021-06-15 | Apicore Us Llc | Process of making regadenoson and novel polymorphs thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
MX2019011926A (en) | Methods useful in the synthesis of halichondrin b analogs. | |
EP3082817A4 (en) | Compositions for drug administration | |
IN2013MU00711A (en) | ||
IN2013MU03641A (en) | ||
MX2017001487A (en) | Sofosbuvir in crystalline form and process for its preparation. | |
MX2016015464A (en) | Oral pharmaceutical composition of isotretinoin. | |
HUP1300647A2 (en) | Complexes of cyclosporine a and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
IN2013MU01985A (en) | ||
EP3020417A4 (en) | Pharmaceutical composition for respiratory administration | |
EP3318259A4 (en) | Stable pharmaceutical composition for oral administration | |
IN2013MU01111A (en) | ||
MX356851B (en) | Use of tungsten (vi) salts for the treatment of female infertility in non-diabetic mammals. | |
IL245260B (en) | A crystalline anhydrous form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof | |
IN2013CH04314A (en) | ||
IN2013MU01226A (en) | ||
IN2013MU03565A (en) | ||
WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
IN2013MU01160A (en) | ||
WO2014147464A3 (en) | Novel process for the preparation of tolcapone | |
IN2014CH01391A (en) | ||
MX355103B (en) | COMPOSITION FOR THE TREATMENT OF INFLAMMATORY and IMMUNE DISORDERS. | |
IN2013MU03656A (en) | ||
IN2013MU03310A (en) | ||
WO2014108921A3 (en) | Carvedilol phosphate solid dispersion |